Quantcast
Home > Quotes > CBLI
CBLI

Cleveland BioLabs, Inc. Common Stock (CBLI) Quote & Summary Data

$1.41
*  
0.01
0.7%
Get CBLI Alerts
*Delayed - data as of Aug. 16, 2019  -  Find a broker to begin trading CBLI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 1.425 / $ 1.41
Share Volume
4,438
50 Day Avg. Daily Volume
3,805
Previous Close
$ 1.42
52 Week High / Low
$ 2.16 / $ 1
Market Cap
15,930,517
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.69

Intraday Chart

Shares Traded

Share Volume:
4,438
50 Day Avg. Daily Volume:
3,805

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.30

Trading Range

The current last sale of $1.41 is 41.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 1.425 $ 2.16
 Low: $ 1.41 $ 1

Company Description (as filed with the SEC)

When used in this Annual Report on Form 10-K, unless otherwise stated or the context otherwise requires, the terms "Cleveland BioLabs," the "Company," "CBLI," "we," "us," and "our" refer to Cleveland BioLabs, Inc. and its consolidated subsidiaries, BioLab 612, LLC and Panacela Labs, Inc. GENERAL OVERVIEW Cleveland BioLabs is an innovative biopharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. We combine our proven scientific expertise and our depth of knowledge about our products' mechanisms of action into a passion for developing drugs to save lives.  ... More ...  

Nasdaq Official Price

Open Price:
$ 1.425
Open Date:
Aug. 16, 2019
Close Price:
$ 1.41
Close Date:
Aug. 16, 2019


Research Brokers before you trade

Want to trade FX?

Analyst Info